Does IDELALISIB Cause Mobility decreased? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Mobility decreased have been filed in association with IDELALISIB (Zydelig). This represents 0.2% of all adverse event reports for IDELALISIB.
16
Reports of Mobility decreased with IDELALISIB
0.2%
of all IDELALISIB reports
2
Deaths
13
Hospitalizations
How Dangerous Is Mobility decreased From IDELALISIB?
Of the 16 reports, 2 (12.5%) resulted in death, 13 (81.3%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IDELALISIB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does IDELALISIB Cause?
Disease progression (1,204)
Death (779)
Diarrhoea (752)
Off label use (548)
Pneumonia (426)
Pyrexia (371)
Drug ineffective (294)
Fatigue (284)
Dehydration (242)
Dyspnoea (206)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which IDELALISIB Alternatives Have Lower Mobility decreased Risk?
IDELALISIB vs IDURSULFASE
IDELALISIB vs IFOSFAMIDE
IDELALISIB vs IGURATIMOD
IDELALISIB vs ILOPERIDONE
IDELALISIB vs ILOPROST